Global Preventive Vaccines Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Vaccine Type;

Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vector Vaccines, DNA Vaccines and Others.

Segmented by Disease Indication;

Pneumococcal Vaccines, Poliovirus, Hepatitis, Influenza, Measles, Mumps, Rubella (MMR), Varicella, Human Papilloma Virus and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn441549767 Published Date: April, 2022 Updated Date: May, 2022

Introduction

Global Preventive Vaccines Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 57.8
2019 62.1
2020 72.7
2021 74.1
2022 86.9
2023 96.3
2024 113.6
2025 124.7
2026 149.1
2027 177.0
2028 194.5

In the year 2021, the Global Preventive Vaccines Market was valued at USD 51,928.87 million. The size of this market is expected to increase to USD 109,592.86 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 11.3%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Vaccine Type
    2. Market Snapshot, By Disease Indication
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Preventive Vaccines Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Prevalence of Infectious Diseases
        2. Innovative Technology in Vaccine Development
        3. Increased Funding from Government and International Organizations
        4. Growing Awareness on Preventive Care
      2. Restraints
        1. Risk of Adverse Effects
        2. Huge Capital Expenditures
      3. Opportunities
    2. Regulatory Scenario
    3. Pipeline Analysis/Technological Advancements
    4. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    5. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Preventive Vaccines Market, By Vaccine Type, 2018 - 2028 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Live/Attenuated Vaccines
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Inactivated Vaccines
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Subunit Vaccines
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Toxoid Vaccines
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Conjugate Vaccines
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        6. Recombinant Vector Vaccines
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        7. DNA Vaccines
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        8. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Preventive Vaccines Market, By Disease Indication, 2018 - 2028 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Pneumococcal Vaccines
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Poliovirus
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Hepatitis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Influenza
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Measles
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        6. Mumps
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        7. Rubella (MMR)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        8. Varicella
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        9. Human Papilloma Virus
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        10. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Preventive Vaccines Market, By Geography, 2018 - 2028 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
        4. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
        5. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. AstraZeneca Plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Emergent Biosolutions
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. GeoVax
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. GlaxoSmithKline Plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Inovio Pharmaceuticals
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Johnson & Johnson
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Merck & Co., Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Novartis AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Pfizer, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Sanofi S.A.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare In Vitro Diagnostics Primary Care Point of Care (POC) Diagnostics
Global Primary Care Point of Care (POC) Diagnostics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Primary Care Point of Care (POC) Diagnostics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Primary Cell Culture
Global Primary Cell Culture Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Primary Cell Culture Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Primary Cells
Global Primary Cells Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Primary Cells Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Liver Disease
Global Primary Sclerosing Cholangitis Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Primary Sclerosing Cholangitis Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...